| Title | Phase 1/2, Multicenter, Open-label, Multiple-Dose First-in-human Study of U3-1402, in Subjects With HER3 Positive Metastatic Breast Cancer |
|---|---|
| Disease/Condition | Breast Cancer,Skin Disorders,Metastatic Cancer,Oncology (Medical/Hematologic),Neoplasms |
| Description | |
| Eligibility Criteria | Click here for eligibility requirements |
| Principal Investigator | Sun Young Oh, MD |
| Contact Name | Amanda Erakky |
| Contact Email | aerakky@montefiore.org |
| Protocol Number | 18-06-198Q-01 |
| Inclusion/Notes | This Information was obtained from ClinicalTrials.gov |
| Status | Active/Enrolling |
| Adult Clinical Trial | Yes |
| Pediatric Clinical Trial | No |
| Sub-Specialty | Medical and Hematologic Oncology - Breast |
| Adult, Pediatric, Both | Adult |